Concepedia

Author

Keith Wilcoxen

Neurocrine Biosciences (United States)

Also Known As

K. M. WILCOXEN, K. WILCOXEN, K. Wilcoxen, K.M. Wilcoxen, Keith M Wilcoxen, Keith M. Wilcoxen, Keith Matthew Wilcoxen, Keith Wilcoxen, Wilcoxen Keith, Wilcoxen, K.M.

88

Publications

2.8K

Citations

25

H-Index

66

Concepts

All Affiliations

Neurocrine Biosciences (United States)Tesaro (United States)Scripps Research InstituteMayo Clinic in Arizona
KW

About

Keith Wilcoxen is an author at Neurocrine Biosciences (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

24

1.8K

2

Natural Sciences

9

9

301

3

Engineering

6

6

272

4

Allergy

2

2

59

5

Health Sciences

1

1

13

Keith Wilcoxen

×

43

Publications

2.6K

Citations

25

H-Index

YearCitations

Antibacterial agents based on the cyclic d,l-α-peptide architecture

Sara Fernandez‐Lopez, Hui-Sun Kim, Ellen C. Choi,

Nature

2001

932

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity

Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga,

Journal of Virology

2022

183

Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination

Philip Jones, Keith Wilcoxen, Michael Rowley,

Journal of Medicinal Chemistry

2015

181

Antiviral cyclic d,l-α-peptides: Targeting a general biochemical pathway in virus infections

W. Seth Horne, Christopher M. Wiethoff, Cui Chunli,

Bioorganic & Medicinal Chemistry

2005

126

Design of 2,5-Dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-<i>a</i>]pyrimidine (NBI 30775/R121919) and Structure−Activity Relationships of a Series of Potent and Orally Active Corticotropin-Releasing Factor Receptor Antagonists

Chen Chen, Keith Wilcoxen, Charles Q. Huang,

Journal of Medicinal Chemistry

2004

117

Coupling of 2-Substituted 1-Fluorovinylstannanes with Organic Halides Catalyzed by Palladium(0)/Copper(I) Iodide. A Mild and Stereospecific Method to Monofluoroolefins

Chen Chen, Keith Wilcoxen, Yunfei Zhu,

The Journal of Organic Chemistry

1999

80

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma

Mariam AlHilli, Marc A. Becker, S. John Weroha,

Gynecologic Oncology

2016

75

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition

Gayathri Srinivasan, Gurjit Sidhu, Elizabeth A. Williamson,

Cancer Chemotherapy and Pharmacology

2017

61

Automated Mass Spectrometric Sequence Determination of Cyclic Peptide Library Members

James E. Redman, Keith Wilcoxen, M. Reza Ghadiri

Journal of Combinatorial Chemistry

2002

59

New methods for the synthesis of fluoroolefins via the palladium catalyzed cross-coupling reaction of 1-fluorovinyl halides with organoboranes and organostannanes

Chen Chen, Keith Wilcoxen, Charles Q. Huang,

Journal of Fluorine Chemistry

2000

49

Page 1